Cryo-Cell International, Inc. - CCEL Company Value to Revenue

Cryo-Cell International (CCEL) - corporate logo

The EV/Sales trajectory for Cryo-Cell International (CCEL) on GURU.Markets contains data where the value 1222.29 indicates the asset's status. Efficient biomaterial logistics via third-party operators minimize risks. Stable management is developing GMP services and cell therapy, ensuring a transparent cash flow. The implementation of energy-saving cooling systems and clean energy optimizes the environmental footprint of Cryo-Cell International.

cryo-cell.com (CCEL): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

Financial and market metric breakdowns for Cryo-Cell International, Inc. (CCEL)

- stock value and consensus price forecast:
Fundamental company valuation:CCEL (Cryo-Cell International Inc)
Flagship merchandise of cryo-cell.com

The stable management of Cryo-Cell International (CCEL) effectively converts free cash flow into the development of biomedical research and the expansion of its cell storage network. This enterprise value-to-revenue ratio combines market capitalization with net debt, eliminating financial distortions to assess the real value of operating income, which allows investors to determine the maturity of the business model and the resilience of market expectations.